Amarin Corp Plcuk (AMRN) Shares Outstanding (Diluted Average) (2010 - 2025)

Amarin Corp Plcuk (AMRN) reported Shares Outstanding (Diluted Average) of $413.4 million for Q1 2025, up 0.8% year-over-year from $410.1 million in Q1 2024, and up 0.8% quarter-over-quarter from $410.1 million in Q1 2024.

Amarin Corp Plcuk (AMRN) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of Shares Outstanding (Diluted Average) data on file, last reported at $413.4 million in Q1 2025.

  • Shares Outstanding (Diluted Average) for Q1 2025 came in at $413.4 million, up 0.8% year-over-year; the trailing twelve-month figure through Mar 2025 was $413.4 million (up 0.8% YoY), and the FY2020 annual result was $381.8 million, up 11.45% from the prior year.
  • Shares Outstanding (Diluted Average) climbed to $413.4 million in Q1 2025 per AMRN's latest filing, from $410.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $413.4 million in Q1 2025 and troughed at $394.6 million in Q1 2021.
  • A 4-year average of $402.3 million and a median of $397.8 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Diluted Average) climbed 9.28% in 2021, then climbed 0.8% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $395.7 million in 2021, then climbed by 0.54% to $397.8 million in 2022, then increased by 3.1% to $410.1 million in 2024, then grew by 0.8% to $413.4 million in 2025.
  • Business Quant data shows AMRN's Shares Outstanding (Diluted Average) at $413.4 million in Q1 2025, $410.1 million in Q1 2024, and $397.8 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 895.90 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.45 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 544.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.25 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.73 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 413.42 Mn
Mar 31, 2024 410.15 Mn
Mar 31, 2022 397.81 Mn
Sep 30, 2021 395.68 Mn
Mar 31, 2021 394.64 Mn
Dec 31, 2020 381.76 Mn
Sep 30, 2020 389.70 Mn
Mar 31, 2020 361.14 Mn
Dec 31, 2019 342.54 Mn
Sep 30, 2019 336.94 Mn
Jun 30, 2019 329.79 Mn
Mar 31, 2019 328.71 Mn
Dec 31, 2018 297.24 Mn
Sep 30, 2018 295.60 Mn
Jun 30, 2018 289.46 Mn
Mar 31, 2018 285.21 Mn
Dec 31, 2017 270.65 Mn
Sep 30, 2017 270.57 Mn
Jun 30, 2017 270.73 Mn
Mar 31, 2017 270.16 Mn